Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
Concord Cancer Centre, Concord Repatriation General Hospital, Hospital Rd., Concord, NSW, 2137, Australia.
Support Care Cancer. 2022 Apr;30(4):3503-3512. doi: 10.1007/s00520-022-06804-1. Epub 2022 Jan 11.
Studies in 1983 and 1993 identified and ranked symptoms experienced by cancer patients receiving chemotherapy. We repeated the studies to obtain updated information on patient perceptions of chemotherapy-associated symptoms.
A cross-sectional interview and patient-reported outcome questionnaires were administered to out-patients receiving chemotherapy. Patients selected from 124 cards to identify and rank the severity of physical and non-physical symptoms they had experienced and attributed to chemotherapy (primary endpoint). The patient's medical oncologist and primary chemotherapy nurse were invited to rank the five symptoms they believed the patient would rank as their most severe. We analysed the association of symptoms and their severity with patient demographics, chemotherapy regimen, and patient-reported outcomes. Results were compared to the earlier studies.
Overall, 302 patients completed the interview: median age 58 years (range 17-85); 56% female; main tumour types colorectal 81 (27%), breast 67 (22%), lung 49 (16%); 45% treated with curative intent. Most common symptoms (reported by >50%) were: alopecia, general weakness, effects on family/partner, loss of taste, nausea, fatigue, difficulty sleeping, effects on work/home duties, and having to put life on hold. The most severe symptoms (ranked by >15% in top five) were: concern about effects on family/partner, nausea, fear of the future, fatigue, not knowing what will happen, putting my life on hold, and general weakness. Perceptions of doctors and nurses of patients' symptom severity closely matched patients' rankings.
Compared to earlier studies, there was an increase in non-physical concerns such as effects on family and future, and a decrease in physical symptoms, particularly vomiting, but nausea, fatigue and general weakness remained bothersome.
• Symptoms related to chemotherapy have changed over time, likely due to less toxic regimens and improvements in supportive care. • Effects on family/partner, fear of the future, not knowing what will happen, and "life on hold" were major issues for patients. • Vomiting has decreased but nausea, fatigue and general weakness remain common symptoms for chemotherapy patients.
1983 年和 1993 年的研究确定并对接受化疗的癌症患者的症状进行了排序。我们重复这些研究,以获取有关患者对化疗相关症状的看法的最新信息。
对接受化疗的门诊患者进行了横断面访谈和患者报告的结果问卷调查。患者从 124 张卡片中选出并对他们经历过的身体和非身体症状及其归因于化疗的严重程度进行了排序(主要终点)。邀请患者的肿瘤内科医生和主要化疗护士对他们认为患者会将其列为最严重的五种症状进行排序。我们分析了症状及其严重程度与患者人口统计学、化疗方案和患者报告结果之间的关系。结果与早期研究进行了比较。
共有 302 名患者完成了访谈:中位年龄 58 岁(范围 17-85);56%为女性;主要肿瘤类型为结直肠癌 81 例(27%),乳腺癌 67 例(22%),肺癌 49 例(16%);45%为治愈性治疗。最常见的症状(报告率>50%)是:脱发、全身乏力、对家庭/伴侣的影响、味觉丧失、恶心、疲劳、睡眠困难、对工作/家庭责任的影响以及不得不搁置生活。最严重的症状(排名前五位中有>15%的患者选择)是:担心对家庭/伴侣的影响、恶心、对未来的恐惧、疲劳、不知道会发生什么、搁置我的生活以及全身乏力。医生和护士对患者症状严重程度的看法与患者的排序非常吻合。
与早期研究相比,非身体方面的担忧(如对家庭和未来的影响)有所增加,身体症状(尤其是呕吐)有所减少,但恶心、疲劳和全身乏力仍然是困扰患者的主要问题。
与化疗相关的症状随时间发生了变化,可能是由于毒性较小的治疗方案和支持性护理的改善。
对家庭/伴侣、对未来的恐惧、不知道会发生什么以及“生活搁置”是患者的主要问题。
呕吐减少,但恶心、疲劳和全身乏力仍然是化疗患者的常见症状。